Kwality Pharmaceuticals Ltd
₹1664.30
(-4.73%)
Thu, 30 Apr 2026, 03:02 pm
Kwality Pharmaceuticals Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 54.87 | 54.83 | 54.83 | 54.83 | 54.83 |
| FII | 2.79 | 0.50 | 0 | 0 | 0 |
| DII | 0.36 | 0.33 | 0.33 | 0.33 | 0.32 |
| Public | 41.98 | 44.34 | 44.84 | 44.84 | 44.86 |
| Government | 0 | 0 | 0 | 0 | 0 |
Kwality Pharmaceuticals Ltd Shareholding Pattern
The Kwality Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Kwality Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Kwality Pharmaceuticals Ltd (NSE: , BSE: 539997) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Kwality Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Kwality Pharmaceuticals Ltd Shareholding Pattern (Latest)
The latest Kwality Pharmaceuticals Ltd shareholding for Mar 2026 is:
- Promoters: 54.87%
- FII: 2.79%
- DII: 0.36%
- Public: 41.98%
- Government: 0%
Promoter holding in Kwality Pharmaceuticals Ltd has increased, indicating strong confidence from company promoters.
Kwality Pharmaceuticals Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Kwality Pharmaceuticals Ltd.
- Mar 2026: 54.87%
- Dec 2025: 54.83%
- Sept 2025: 54.83%
- Jun 2025: 54.83%
- Mar 2025: 54.83%
Promoter stake in Kwality Pharmaceuticals Ltd has increased, indicating strong long-term confidence.
Kwality Pharmaceuticals Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Kwality Pharmaceuticals Ltd.
- Mar 2026: 2.79%
- Dec 2025: 0.50%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
FII holding in Kwality Pharmaceuticals Ltd has increased recently, indicating rising foreign investor interest.
Kwality Pharmaceuticals Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 0.36%
- Dec 2025: 0.33%
- Sept 2025: 0.33%
- Jun 2025: 0.33%
- Mar 2025: 0.32%
DII stake in Kwality Pharmaceuticals Ltd has increased over time, indicating growing domestic institutional confidence.
Kwality Pharmaceuticals Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 41.98%
- Dec 2025: 44.34%
- Sept 2025: 44.84%
- Jun 2025: 44.84%
- Mar 2025: 44.86%
Public holding remains stable with consistent retail participation.
Kwality Pharmaceuticals Ltd Government Holding
Government holding in Kwality Pharmaceuticals Ltd currently stands at 0%.
Kwality Pharmaceuticals Ltd operates without significant government ownership.
Kwality Pharmaceuticals Ltd Shareholding Analysis Summary
The Kwality Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Kwality Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Kwality Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800